A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
- Status
- COMPLETED
- Phase
- PHASE2
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine + Carboplatin in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC
- Status
- TERMINATED
- Phase
- PHASE3
Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
- Status
- UNKNOWN
- Phase
- PHASE3